92 related articles for article (PubMed ID: 6346687)
1. [Inactivated vaccine against Japanese encephalitis. The characteristics of a purified preparation from mouse brain].
El'bert LB; Semenov BF; Karaseva PS; Pervikov IuV; Krutianskaia GL
Vopr Virusol; 1983; (2):196-200. PubMed ID: 6346687
[TBL] [Abstract][Full Text] [Related]
2. [Immunogenicity and stability of a Soviet inactivated cultured vaccine against Japanese encephalitis].
Khanina MK; Bochkova NG; Grachev VP; El'bert LB; Vorob'eva MS; Borsuk EA; Pogodina VV
Vopr Virusol; 1990; 35(6):478-80. PubMed ID: 2082551
[TBL] [Abstract][Full Text] [Related]
3. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the reactogenicity and immunogenicity of new Soviet and commercial vaccines for preventing Japanese encephalitis].
Sumarovkov AA; Grachev VP; Kharazian EG; Shkol'nik RIa; Vorob'eva MS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):74-9. PubMed ID: 6314716
[TBL] [Abstract][Full Text] [Related]
5. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
Wills MR; Sil BK; Cao JX; Yu YX; Barrett AD
Vaccine; 1992; 10(12):861-72. PubMed ID: 1455912
[TBL] [Abstract][Full Text] [Related]
7. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses.
Wills MR; Singh BK; Debnath NC; Barrett AD
Vaccine; 1993; 11(7):761-6. PubMed ID: 8342323
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
10. Protection against Japanese encephalitis by inactivated vaccines.
Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
[TBL] [Abstract][Full Text] [Related]
11. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
Ferguson M; Johnes S; Li L; Heath A; Barrett A
Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
[TBL] [Abstract][Full Text] [Related]
12. Indirect haemagglutination test for the assay of antibodies against Japanese encephalitis viral antigen in human & animal sera.
Gupta RK; Misra CN; Mehta VK; Gupta VK; Bhau LN; Singh G; Gowal D; Saxena SN
Indian J Med Res; 1990 Sep; 91():315-20. PubMed ID: 2269502
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Okuno Y; Fukunaga T; Tadano M; Fukai K; Baba K; Tsuda N; Yamada A; Yabuuchi H
Biken J; 1983 Mar; 26(1):25-34. PubMed ID: 6626137
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Fukai K
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Sep; 16(3):190-7. PubMed ID: 6680096
[TBL] [Abstract][Full Text] [Related]
15. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
[TBL] [Abstract][Full Text] [Related]
16. A test production of inactivated mouse brain JE vaccine in Thailand.
Pongpairoj S; Choakouychai B; Boonrueng C; Kutirakan P; Ahandrik S; Leelasiri K; Phanthumachinda B
Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):647-52. PubMed ID: 2561721
[No Abstract] [Full Text] [Related]
17. Neutralization antibody responses induced by Japanese encephalitis virus vaccine.
Susilowati S; Okuno Y; Fukunaga T; Tadano M; Juang RF; Fukai K
Biken J; 1981 Dec; 24(4):137-45. PubMed ID: 7346039
[TBL] [Abstract][Full Text] [Related]
18. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
[TBL] [Abstract][Full Text] [Related]
19. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
20. [Tissue culture inactivated vaccine for the prevention of Japanese encephalitis: experimental and laboratory process and control layout].
Loginova IV; Deriabin PG; Tikhomirov EE; Karpova EF
Vopr Virusol; 2007; 52(3):26-9. PubMed ID: 17601048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
